Efficacy and Safety of Relacorilant for the Treatment of Patients With Cushing’s Syndrome (GRACE): A Multicentre, Phase 3, Double-Blind, Placebo-Controlled, Randomised-Withdrawal Study

Published Online: The Lancet Diabetes & Endocrinology, 20 February 2026. doi: 10.1016/S2213-8587(25)00362-6.

Authors: Pivonello R, Arnaldi G, Auchus RJ, et al.

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.